Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.65 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.57 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | P4HB | P07237 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25001338 | 0.88 | KMT2A (0.60) | KMT2APAX8HSD11B1ALDH1A1LMNA | |
| SCHEMBL23480400 | 0.83 | KMT2A (0.69) | KMT2APAX8HSD11B1ALDH1A1LMNA | |
| SCHEMBL25002674 | 0.81 | PAX8 (0.56) | KMT2APAX8ALDH1A1LMNATP53 | |
| SCHEMBL29275318 | 0.81 | HSD11B1 (0.78) | KMT2APAX8HSD11B1ALDH1A1LMNA | |
| SCHEMBL23734595 | 0.75 | KMT2A (0.55) | KMT2APAX8HSD11B1ALDH1A1LMNA | |
| SCHEMBL1951415 | 0.74 | KMT2A (0.76) | KMT2APAX8HSD11B1ALDH1A1LMNA | |
| SCHEMBL25128778 | 0.74 | KMT2A (0.76) | KMT2APAX8HSD11B1ALDH1A1LMNA | |
| SCHEMBL4617628 | 0.72 | KMT2A (0.74) | KMT2APAX8HSD11B1ALDH1A1LMNA | |
| SCHEMBL28825135 | 0.72 | KMT2A (1.00) | KMT2APAX8HSD11B1ALDH1A1LMNA | |
| SCHEMBL28825174 | 0.72 | KMT2A (1.00) | KMT2APAX8HSD11B1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230039858-A1 | COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION | INTOCELL, INC. (KR) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230039858-A1 | COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION | FCGR2A, FCGRT, FCGR3B | KMT2A 832/4885PAX8 4289/4885HSD11B1 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.